Coronavirus: Belgian experts ‘shocked’ as AstraZeneca seeks liability waiver for vaccine

[flatlander]

I think this will become an important data point when states, businesses, schools, etc. in the US mandate vaccines for people.

Coronavirus: Belgian experts ‘shocked’ as AstraZeneca seeks liability waiver for vaccine

Friday, 21 August 2020

https://www.brusselstimes.com/belgi...trazeneca-seeks-liability-waiver-for-vaccine/

 

[Emily]

"Dobber said that AstraZeneca could “simply not take the risk” of being faced with liability claims if “in four years the vaccine is showing side effects.”"

Four years? What the heck are they afraid of going wrong that far down the line? If they want their customers to be confident, they should be more confident themselves.

 

[Vibrant62]

They are concerned about the potential for ADE responses somewhere down the line i.e when there is a significantly mutated variety of the virus. It simply cannot be ruled in or out by anyone at this point.

 

[sharon sanders]

AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.


By REBECCA ROBBINS @rebeccadrobbins, ADAM FEUERSTEIN @adamfeuerstein, and HELEN BRANSWELL @HelenBranswell

SEPTEMBER 8, 2020

https://www.statnews.com/2020/09/08...m_source=twitter&utm_campaign=twitter_organic

 

[sharon sanders]

h/t @jwgale

posted with permission


AstraZeneca Pauses Vaccine Trial After Unexplained Illness (1)
2020-09-08 22:15:50.417 GMT


By Riley Griffin and Timothy Annett
(Bloomberg) -- AstraZeneca Plc said that it had paused
research on its experimental coronavirus vaccine after a person
who was participating in a clinical trial became ill.
The vaccine, which AstraZeneca is developing with
researchers from the University of Oxford, has been viewed as
one of the leading candidates to reach the market. The decision
to tap the brakes jolted investors, sending AstraZeneca’s U.S.-
traded shares down sharply, while boosting the stocks of some
rivals developing different potential Covid-19 shots.
“This is a routine action which has to happen whenever
there is a potentially unexplained illness in one of the trials,
while it is investigated, ensuring we maintain the integrity of
the trials,” AstraZeneca spokesperson Michele Meixell said in a
statement.
Meixell said that the company was working to expedite its
review of the incident in order to keep the trial moving along.
Companies have been racing to find a Covid-19 vaccine quickly in
hopes of blunting the pandemic as another flu season looms in
the Northern Hemisphere.
News of the trial setback was first reported by STAT.
In late trading in New York, AstraZeneca shares fell as
much as 8.3%, while Moderna Inc. and BioNTech SE saw their
shares rise. All three companies are participating in Operation
Warp Speed, the Trump administration’s program to accelerate the
discovery and distribution of a viable inoculation.
Oxford University’s Jenner Institute didn’t immediately
respond to requests seeking comment.

 

[sharon sanders]

fyi - I copied a post from the discussion forum to start this thread to add today's new information.

 

[Mary Wilson]

LIVE UPDATES
Updated Sept. 8, 2020, 9:58 p.m. ET

AstraZeneca halts a vaccine trial to investigate a participant’s illness.

The company said it was “working to expedite the review of the single event to minimize any potential impact on the trial timeline” and that it was “committed to the safety of our participants and the highest standards of conduct in our trials.”

A person familiar with the situation, and who spoke on the condition of anonymity, said that the participant had been enrolled in a Phase 2/3 trial based in the United Kingdom. The individual also said that a volunteer in the U.K. trial had been found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by viral infections. However, the timing of this diagnosis, and whether it was directly linked to AstraZeneca’s vaccine, is unclear.

https://www.nytimes.com/2020/09/08/world/covid-19-coronavirus.html

 

[Gert van der Hoek]

Makes you wonder: 2 weeks ago AstraZeneca wanted to talk about liability, now this.

 

[sharon sanders]

Agree. Interesting. This is why I copied flatlander's post out of the discussion forum. Main street media gets some flashy headlines but we have a lot of context here.